The European Medicines Agency (EMA) is taking 'rapid action' to ensure that study results are made public as required by law, following a recent analysis found results for less than half of the studies registered in a key European database were reported within the required time frame.[5280784] This move comes after a review found overall compliance with legal reporting requirements was weak and regulatory oversight is lacking.[5280784] The analysis of the Clinical Trial Information System (CTIS) was the first to examine the database, which contains more than 8,400 mid- and late-stage trials.[5280784] In related news, the White House and the Department of Health and Human Services will convene experts to discuss standards for clinical artificial intelligence.[5259971] The goal of this discussion is to arrive at a consensus set of principles for benchmarking and evaluating clinical AI.[5259971]